Synovus Financial Corp Abb Vie Inc. Transaction History

Synovus Financial Corp

$8.56 Billion
Q3 2024

A detailed history of Synovus Financial Corp transactions in Abb Vie Inc. stock. As of the latest transaction made, Synovus Financial Corp holds 129,684 shares of ABBV stock, worth $23.3 Million. This represents 0.3% of its overall portfolio holdings.

Number of Shares

129,684

Previous 129,684 -0.0%

Holding current value

$23.3 Million

Previous $25.6 Million -0.0%

% of portfolio

0.3%

Previous 0.27%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$163.84 - $199.33 $212,172 - $258,132	-1,295 Reduced 0.99%	129,684 $25.6 Million
Q2 2024 Aug 13, 2024	SELL	$154.79 - $180.76 $197,666 - $230,830	-1,277 Reduced 0.97%	130,979 $22.5 Million
Q1 2024 May 14, 2024	BUY	$159.82 - $182.1 $2.15 Million - $2.45 Million	13,461 Added 11.33%	132,256 $24.1 Million
Q3 2023 Nov 13, 2023	BUY	$133.59 - $154.65 $820,109 - $949,396	6,139 Added 5.45%	118,795 $17.7 Million
Q2 2023 Aug 08, 2023	SELL	$132.51 - $164.9 $790,687 - $983,958	-5,967 Reduced 5.03%	112,656 $15.2 Million
Q1 2023 May 11, 2023	SELL	$144.61 - $166.54 $318,142 - $366,388	-2,200 Reduced 1.82%	118,623 $18.9 Million
Q4 2022 Feb 06, 2023	BUY	$138.31 - $165.87 $404,556 - $485,169	2,925 Added 2.48%	120,823 $19.5 Million
Q3 2022 Oct 27, 2022	BUY	$134.21 - $153.93 $170,849 - $195,952	1,273 Added 1.09%	117,898 $15.8 Million
Q2 2022 Aug 10, 2022	BUY	$137.62 - $174.96 $246,890 - $313,878	1,794 Added 1.56%	116,625 $17.9 Million
Q1 2022 May 12, 2022	SELL	$131.98 - $163.75 $628,356 - $779,613	-4,761 Reduced 3.98%	114,831 $18.6 Million
Q4 2021 Feb 14, 2022	BUY	$107.43 - $135.93 $111,727 - $141,367	1,040 Added 0.88%	119,592 $16.2 Million
Q3 2021 Nov 08, 2021	SELL	$106.4 - $120.78 $276,852 - $314,269	-2,602 Reduced 2.15%	118,552 $12.8 Million
Q2 2021 Aug 11, 2021	BUY	$105.21 - $117.21 $31,878 - $35,514	303 Added 0.25%	121,154 $13.7 Million
Q1 2021 May 11, 2021	SELL	$102.3 - $112.62 $432,524 - $476,157	-4,228 Reduced 3.38%	120,851 $13.1 Million
Q4 2020 Feb 11, 2021	SELL	$80.49 - $108.67 $316,889 - $427,833	-3,937 Reduced 3.05%	125,079 $13.4 Million
Q3 2020 Nov 09, 2020	SELL	$85.91 - $100.83 $47,765 - $56,061	-556 Reduced 0.43%	129,016 $11.3 Million
Q2 2020 Aug 10, 2020	SELL	$73.37 - $98.18 $913,383 - $1.22 Million	-12,449 Reduced 8.77%	129,572 $12.7 Million
Q1 2020 Apr 24, 2020	BUY	$64.5 - $97.79 $2.19 Million - $3.32 Million	34,000 Added 31.48%	142,021 $10.8 Million
Q4 2019 Feb 06, 2020	SELL	$72.13 - $90.25 $96,221 - $120,393	-1,334 Reduced 1.22%	108,021 $9.57 Million
Q3 2019 Nov 01, 2019	BUY	$62.98 - $75.72 $107,254 - $128,951	1,703 Added 1.58%	109,355 $8.28 Million
Q2 2019 Aug 08, 2019	SELL	$65.7 - $83.98 $1.05 Million - $1.34 Million	-15,951 Reduced 12.91%	107,652 $7.84 Million
Q1 2019 May 09, 2019	SELL	$77.14 - $90.79 $3.8 Million - $4.47 Million	-49,221 Reduced 28.48%	123,603 $9.95 Million
Q4 2018 Feb 07, 2019	BUY	$77.85 - $96.01 $80,107 - $98,794	1,029 Added 0.6%	172,824 $15.9 Million
Q3 2018 Nov 01, 2018	BUY	$88.91 - $98.84 $301,227 - $334,869	3,388 Added 2.01%	171,795 $16.2 Million
Q2 2018 Aug 01, 2018	BUY	$89.78 - $106.23 $401,945 - $475,591	4,477 Added 2.73%	168,407 $15.6 Million
Q1 2018 May 07, 2018	SELL	$92.01 - $123.21 $411,376 - $550,871	-4,471 Reduced 2.65%	163,930 $15.5 Million
Q4 2017 Feb 09, 2018	BUY	$89.56 - $98.21 $235,005 - $257,703	2,624 Added 1.58%	168,401 $16.3 Million
Q3 2017 Nov 13, 2017	BUY	$69.85 - $89.22 $11.6 Million - $14.8 Million	165,777	165,777 $14.7 Million

Others Institutions Holding ABBV

# of Institutions

3,853

Shares Held

1.25B

Call Options Held

16.8M

Put Options Held

12.2M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $318B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Synovus Financial Corp, based on Form 13F filings with the SEC.

News

Stay updated on Synovus Financial Corp with notifications on news.

Account

Synovus Financial Corp Abb Vie Inc. Transaction History